Ratio-Dependent Regulation of Butyrate Production by 2′-Fucosyllactose and Fructooligosaccharides in a Bifidobacterium bifidum-Faecalibacterium prausnitzii Co-Culture
Abstract
1. Introduction
2. Materials and Methods
2.1. Chemicals and Bacterial Strains
2.2. Growth Experiments and Co-Culture Experiments
2.3. Quantitative Real-Time PCR
2.4. Organic Acid Analysis
2.5. Statistical Analysis
3. Results
3.1. Effects of 2′-FL and FOS Mixtures on Growth and Organic Acid Production of F. prausnitzii
3.2. Effects of 2′-FL and FOS Mixtures on Growth and Organic Acid Production of B. bifidum
3.3. Effects of 2′-FL and FOS Mixtures on Growth and Organic Acid Production in a Co-Culture of F. prausnitzii and B. bifidum
3.4. Effects of 2′-FL and FOS Mixtures on the Relative Abundances of F. prausnitzii and B. bifidum in Co-Culture
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| 2′-FL | 2′-fucosyllactose |
| ANOVA | analysis of variance |
| CLD | compact letter display |
| FOS | fructooligosaccharides |
| HMOs | human milk oligosaccharides |
| NSC | no-substrate condition |
| qPCR | quantitative PCR |
| SCFAs | short-chain fatty acids |
| SD | standard deviation |
| YCFA | yeast extract-casitone-fatty acid agar |
References
- Plaza-Díaz, J.; Fontana, L.; Gil, A. Human Milk Oligosaccharides and Immune System Development. Nutrients 2018, 10, 1038. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ayechu-Muruzabal, V.; van Stigt, A.H.; Mank, M.; Willemsen, L.E.M.; Stahl, B.; Garssen, J.; Van’t Land, B. Diversity of Human Milk Oligosaccharides and Effects on Early Life Immune Development. Front. Pediatr. 2018, 6, 239. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, S.; Li, T.; Xie, J.; Zhang, D.; Pi, C.; Zhou, L.; Yang, W. Gold Standard for Nutrition: A Review of Human Milk Oligosaccharide and Its Effects on Infant Gut Microbiota. Microb. Cell Fact. 2021, 20, 108, Erratum in Microb. Cell Fact. 2021, 20, 140. https://doi.org/10.1186/s12934-021-01612-4. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Castanys-Muñoz, E.; Martin, M.J.; Prieto, P.A. 2′-Fucosyllactose: An Abundant, Genetically Determined Soluble Glycan Present in Human Milk. Nutr. Rev. 2013, 71, 773–789. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhou, W.; Jiang, H.; Wang, L.; Liang, X.; Mao, X. Biotechnological Production of 2′-Fucosyllactose: A Prevalent Fucosylated Human Milk Oligosaccharide. ACS Synth. Biol. 2021, 10, 447–458. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Berger, B.; Porta, N.; Foata, F.; Grathwohl, D.; Delley, M.; Moine, D.; Charpagne, A.; Siegwald, L.; Descombes, P.; Alliet, P.; et al. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics. mBio 2020, 11, 10.1128/mbio.03196-19. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alliet, P.; Vandenplas, Y.; Roggero, P.; Jespers, S.N.J.; Peeters, S.; Stalens, J.-P.; Kortman, G.A.M.; Amico, M.; Berger, B.; Sprenger, N.; et al. Safety and Efficacy of a Probiotic-Containing Infant Formula Supplemented with 2′-Fucosyllactose: A Double-Blind Randomized Controlled Trial. Nutr. J. 2022, 21, 11. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Puccio, G.; Alliet, P.; Cajozzo, C.; Janssens, E.; Corsello, G.; Sprenger, N.; Wernimont, S.; Egli, D.; Gosoniu, L.; Steenhout, P. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. J. Pediatr. Gastroenterol. Nutr. 2017, 64, 624–631. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Elison, E.; Vigsnaes, L.K.; Rindom Krogsgaard, L.; Rasmussen, J.; Sørensen, N.; McConnell, B.; Hennet, T.; Sommer, M.O.A.; Bytzer, P. Oral Supplementation of Healthy Adults with 2′-O-Fucosyllactose and Lacto-N-Neotetraose Is Well Tolerated and Shifts the Intestinal Microbiota. Br. J. Nutr. 2016, 116, 1356–1368. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Furusawa, Y.; Obata, Y.; Fukuda, S.; Endo, T.A.; Nakato, G.; Takahashi, D.; Nakanishi, Y.; Uetake, C.; Kato, K.; Kato, T.; et al. Commensal Microbe-Derived Butyrate Induces the Differentiation of Colonic Regulatory T Cells. Nature 2013, 504, 446–450, Erratum in Nature 2014, 506, 254. https://doi.org/10.1038/nature13041. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Peng, K.; Xia, S.; Xiao, S.; Yu, Q. Short-Chain Fatty Acids Affect the Development of Inflammatory Bowel Disease through Intestinal Barrier, Immunology, and Microbiota: A Promising Therapy? J. Gastroenterol. Hepatol. 2022, 37, 1710–1718. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Donohoe, D.R.; Garge, N.; Zhang, X.; Sun, W.; O’Connell, T.M.; Bunger, M.K.; Bultman, S.J. The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon. Cell Metab. 2011, 13, 517–526. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lopez-Siles, M.; Duncan, S.H.; Garcia-Gil, L.J.; Martinez-Medina, M. Faecalibacterium Prausnitzii: From Microbiology to Diagnostics and Prognostics. ISME J. 2017, 11, 841–852. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Centanni, M.; Ferguson, S.A.; Sims, I.M.; Biswas, A.; Tannock, G.W. Bifidobacterium Bifidum ATCC 15696 and Bifidobacterium Breve 24b Metabolic Interaction Based on 2′-O-Fucosyl-Lactose Studied in Steady-State Cultures in a Freter-Style Chemostat. Appl. Environ. Microbiol. 2019, 85, e02783-18. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zabel, B.; Yde, C.C.; Roos, P.; Marcussen, J.; Jensen, H.M.; Salli, K.; Hirvonen, J.; Ouwehand, A.C.; Morovic, W. Novel Genes and Metabolite Trends in Bifidobacterium Longum Subsp. Infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2′-Fucosyllactose. Sci. Rep. 2019, 9, 7983. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dedon, L.R.; Özcan, E.; Rani, A.; Sela, D.A. Bifidobacterium Infantis Metabolizes 2′Fucosyllactose-Derived and Free Fucose Through a Common Catabolic Pathway Resulting in 1,2-Propanediol Secretion. Front. Nutr. 2020, 7, 583397. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zabel, B.E.; Gerdes, S.; Evans, K.C.; Nedveck, D.; Singles, S.K.; Volk, B.; Budinoff, C. Strain-Specific Strategies of 2′-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose Assimilation by Bifidobacterium Longum Subsp. Infantis Bi-26 and ATCC 15697. Sci. Rep. 2020, 10, 15919. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Duncan, S.H.; Barcenilla, A.; Stewart, C.S.; Pryde, S.E.; Flint, H.J. Acetate Utilization and Butyryl Coenzyme A (CoA):Acetate-CoA Transferase in Butyrate-Producing Bacteria from the Human Large Intestine. Appl. Environ. Microbiol. 2002, 68, 5186–5190. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rios-Covian, D.; Gueimonde, M.; Duncan, S.H.; Flint, H.J.; de los Reyes-Gavilan, C.G. Enhanced Butyrate Formation by Cross-Feeding between Faecalibacterium Prausnitzii and Bifidobacterium Adolescentis. FEMS Microbiol. Lett. 2015, 362, fnv176. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Duncan, S.H.; Holtrop, G.; Lobley, G.E.; Calder, A.G.; Stewart, C.S.; Flint, H.J. Contribution of Acetate to Butyrate Formation by Human Faecal Bacteria. Br. J. Nutr. 2004, 91, 915–923. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Verstraeten, S.; Layec, S.; Auger, S.; Juste, C.; Henry, C.; Charif, S.; Jaszczyszyn, Y.; Sokol, H.; Beney, L.; Langella, P.; et al. Faecalibacterium Duncaniae A2-165 Regulates the Expression of Butyrate Synthesis, Ferrous Iron Uptake, and Stress-Response Genes Based on Acetate Consumption. Sci. Rep. 2024, 14, 987. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hu, W.; Gao, W.; Liu, Z.; Fang, Z.; Zhao, J.; Zhang, H.; Lu, W.; Chen, W. Biodiversity and Physiological Characteristics of Novel Faecalibacterium Prausnitzii Strains Isolated from Human Feces. Microorganisms 2022, 10, 297. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cheng, L.; Kiewiet, M.B.G.; Logtenberg, M.J.; Groeneveld, A.; Nauta, A.; Schols, H.A.; Walvoort, M.T.C.; Harmsen, H.J.M.; de Vos, P. Effects of Different Human Milk Oligosaccharides on Growth of Bifidobacteria in Monoculture and Co-Culture With Faecalibacterium Prausnitzii. Front. Microbiol. 2020, 11, 569700. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fernandes, P. Fructooligosaccharides (FOSs): A Condensed Overview. Compounds 2025, 5, 8. [Google Scholar] [CrossRef] [Scilit]
- Singh, V.; Lee, G.; Son, H.; Koh, H.; Kim, E.S.; Unno, T.; Shin, J.-H. Butyrate Producers, “The Sentinel of Gut”: Their Intestinal Significance with and beyond Butyrate, and Prospective Use as Microbial Therapeutics. Front. Microbiol. 2023, 13, 1103836. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tanno, H.; Fujii, T.; Hirano, K.; Maeno, S.; Tonozuka, T.; Sakamoto, M.; Ohkuma, M.; Tochio, T.; Endo, A. Characterization of Fructooligosaccharide Metabolism and Fructooligosaccharide-Degrading Enzymes in Human Commensal Butyrate Producers. Gut Microbes 2021, 13, 1869503. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tochio, T.; Kadota, Y.; Tanaka, T.; Koga, Y. 1-Kestose, the Smallest Fructooligosaccharide Component, Which Efficiently Stimulates Faecalibacterium Prausnitzii as Well as Bifidobacteria in Humans. Foods 2018, 7, 140. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Onodera, H.; Sato, Y.; Komatsu, Y.; Yamashita, M.; Watanabe, Y.; Kokubo, T. HMOs Induce Butyrate Production of Faecalibacterium Prausnitzii via Cross-Feeding by Bifidobacterium Bifidum with Different Mechanisms for HMO Types. Microorganisms 2025, 13, 1705. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Duncan, S.H.; Hold, G.L.; Harmsen, H.J.M.; Stewart, C.S.; Flint, H.J. Growth Requirements and Fermentation Products of Fusobacterium Prausnitzii, and a Proposal to Reclassify It as Faecalibacterium Prausnitzii Gen. Nov., Comb. Nov. Int. J. Syst. Evol. Microbiol. 2002, 52, 2141–2146. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ramirez-Farias, C.; Slezak, K.; Fuller, Z.; Duncan, A.; Holtrop, G.; Louis, P. Effect of Inulin on the Human Gut Microbiota: Stimulation of Bifidobacterium Adolescentis and Faecalibacterium Prausnitzii. Br. J. Nutr. 2008, 101, 541–550. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Drabińska, N.; Jarocka-Cyrta, E.; Markiewicz, L.H.; Krupa-Kozak, U. The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial. Nutrients 2018, 10, 201. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Park, J.-H.; Song, W.-S.; Lee, J.; Jo, S.-H.; Lee, J.-S.; Jeon, H.-J.; Kwon, J.-E.; Kim, Y.-R.; Baek, J.-H.; Kim, M.-G.; et al. An Integrative Multiomics Approach to Characterize Prebiotic Inulin Effects on Faecalibacterium Prausnitzii. Front. Bioeng. Biotechnol. 2022, 10, 825399. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Katayama, T.; Sakuma, A.; Kimura, T.; Makimura, Y.; Hiratake, J.; Sakata, K.; Yamanoi, T.; Kumagai, H.; Yamamoto, K. Molecular Cloning and Characterization of Bifidobacterium Bifidum 1,2-α-l-Fucosidase (AfcA), a Novel Inverting Glycosidase (Glycoside Hydrolase Family 95). J. Bacteriol. 2004, 186, 4885–4893. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liu, S.; Fang, Z.; Wang, H.; Zhai, Q.; Hang, F.; Zhao, J.; Zhang, H.; Lu, W.; Chen, W. Gene–Phenotype Associations Involving Human-Residential Bifidobacteria (HRB) Reveal Significant Species- and Strain-Specificity in Carbohydrate Catabolism. Microorganisms 2021, 9, 883. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Heinken, A.; Khan, M.T.; Paglia, G.; Rodionov, D.A.; Harmsen, H.J.M.; Thiele, I. Functional Metabolic Map of Faecalibacterium Prausnitzii, a Beneficial Human Gut Microbe. J. Bacteriol. 2014, 196, 3289–3302. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sato, Y.; Kanayama, M.; Nakajima, S.; Hishida, Y.; Watanabe, Y. Sialyllactose Enhances the Short-Chain Fatty Acid Production and Barrier Function of Gut Epithelial Cells via Nonbifidogenic Modification of the Fecal Microbiome in Human Adults. Microorganisms 2024, 12, 252. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sato, Y.; Kanayama, M.; Nakajima, S.; Komatsu, Y.; Kokubo, T. Comparative Analysis of Fucosyllactose-Induced Changes in Adult Gut Microbiota and Short-Chain Fatty Acid Production Using the Simulator of Human Intestinal Microbial Ecosystem Model. Prev. Nutr. Food Sci. 2025, 30, 331–339. [Google Scholar] [CrossRef] [Scilit] [PubMed]




Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Iguchi, S.; Onodera, H.; Komatsu, Y.; Kokubo, T. Ratio-Dependent Regulation of Butyrate Production by 2′-Fucosyllactose and Fructooligosaccharides in a Bifidobacterium bifidum-Faecalibacterium prausnitzii Co-Culture. Microorganisms 2026, 14, 1812. https://doi.org/10.3390/microorganisms14081812
Iguchi S, Onodera H, Komatsu Y, Kokubo T. Ratio-Dependent Regulation of Butyrate Production by 2′-Fucosyllactose and Fructooligosaccharides in a Bifidobacterium bifidum-Faecalibacterium prausnitzii Co-Culture. Microorganisms. 2026; 14(8):1812. https://doi.org/10.3390/microorganisms14081812
Chicago/Turabian StyleIguchi, Sotaro, Haruka Onodera, Yosuke Komatsu, and Takeshi Kokubo. 2026. "Ratio-Dependent Regulation of Butyrate Production by 2′-Fucosyllactose and Fructooligosaccharides in a Bifidobacterium bifidum-Faecalibacterium prausnitzii Co-Culture" Microorganisms 14, no. 8: 1812. https://doi.org/10.3390/microorganisms14081812
APA StyleIguchi, S., Onodera, H., Komatsu, Y., & Kokubo, T. (2026). Ratio-Dependent Regulation of Butyrate Production by 2′-Fucosyllactose and Fructooligosaccharides in a Bifidobacterium bifidum-Faecalibacterium prausnitzii Co-Culture. Microorganisms, 14(8), 1812. https://doi.org/10.3390/microorganisms14081812

